Cargando…
Information on blinding in registered records of clinical trials
Information on blinding is part of the data that should be provided upon registration of a trial at a clinical trials registry. Reporting of blinding is often absent or of low quality in published articles of clinical trials. This study researched the presence and quality of information on blinding...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522538/ https://www.ncbi.nlm.nih.gov/pubmed/23151201 http://dx.doi.org/10.1186/1745-6215-13-210 |
| _version_ | 1782253082536574976 |
|---|---|
| author | Viergever, Roderik F Ghersi, Davina |
| author_facet | Viergever, Roderik F Ghersi, Davina |
| author_sort | Viergever, Roderik F |
| collection | PubMed |
| description | Information on blinding is part of the data that should be provided upon registration of a trial at a clinical trials registry. Reporting of blinding is often absent or of low quality in published articles of clinical trials. This study researched the presence and quality of information on blinding in registered records of clinical trials and highlights the important role of data-recording formats at clinical trial registries in ensuring high-quality registration. |
| format | Online Article Text |
| id | pubmed-3522538 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35225382012-12-15 Information on blinding in registered records of clinical trials Viergever, Roderik F Ghersi, Davina Trials Letter Information on blinding is part of the data that should be provided upon registration of a trial at a clinical trials registry. Reporting of blinding is often absent or of low quality in published articles of clinical trials. This study researched the presence and quality of information on blinding in registered records of clinical trials and highlights the important role of data-recording formats at clinical trial registries in ensuring high-quality registration. BioMed Central 2012-11-15 /pmc/articles/PMC3522538/ /pubmed/23151201 http://dx.doi.org/10.1186/1745-6215-13-210 Text en Copyright ©2012 Viergever and Ghersi; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Viergever, Roderik F Ghersi, Davina Information on blinding in registered records of clinical trials |
| title | Information on blinding in registered records of clinical trials |
| title_full | Information on blinding in registered records of clinical trials |
| title_fullStr | Information on blinding in registered records of clinical trials |
| title_full_unstemmed | Information on blinding in registered records of clinical trials |
| title_short | Information on blinding in registered records of clinical trials |
| title_sort | information on blinding in registered records of clinical trials |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522538/ https://www.ncbi.nlm.nih.gov/pubmed/23151201 http://dx.doi.org/10.1186/1745-6215-13-210 |
| work_keys_str_mv | AT viergeverroderikf informationonblindinginregisteredrecordsofclinicaltrials AT ghersidavina informationonblindinginregisteredrecordsofclinicaltrials |